Versartis versartis.com


Public lists: Pharma Startups (4732)

Versartis is a biotechnology company developing therapeutics for the treatment of endocrine disorders. The company's lead product candidate is VRS-317, a once monthly form of human growth hormone. Versartis is pursuing the development of new therapeutic proteins utilizing the Amunix half-life extension XTEN technology. XTEN is a hydrophilic sequence of natural amino acids and is expressed as a fusion protein with a therapeutically active peptide or protein. New compounds developed by Versartis u...Show all

Versartis is a biotechnology company developing therapeutics for the treatment of endocrine disorders. The company's lead product candidate is VRS-317, a once monthly form of human growth hormone. Versartis is pursuing the development of new therapeu...Show all

Company (IPO / Went public)

Phone: 650-963-8580

Fax:

275 Shoreline Drive
Suite 450
Redwood City, 94065
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Versartis $258M Mar 21, 2014
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Versartis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Index VenturesVenture CapitalLondon, England, United Kingdom
Aisling CapitalPrivate EquityNew York, New York, United StatesSeries E, Series D, Series C
AmunixCorporationMountain View, California, United StatesSeries D, Series B
Advent Life SciencesVenture CapitalLondon, England, United KingdomSeries E, Series D, Series C, Series B
Medicxi VenturesVenture CapitalLondon, England, United KingdomSeries D, Series C, Series B, Series A
See all 7 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)